Unrivaled Performance In Bull And Bear Markets. FREE TRIALS.
Subscribe Now!
Skip to content

The Arora Report

  • Markets Home
  • Unique ZYX Method
  • Asset Allocation
  • About Nigam Arora
  • FREE TRIALS
  • Markets Home
  • Unique ZYX Method
  • Asset Allocation
  • About Nigam Arora
  • FREE TRIALS
Rss Facebook Twitter Linkedin

A NEW IDEA ON BIOTECH MARAVAI — SUPPLIES A KEY COMPONENT OF CORONAVIRUS VACCINE

  • December 15, 2020
Twitter
LinkedIn
Facebook

Maravai LifeSciences (MRVI) supplies a key component of the coronavirus vaccine produced by Pfizer (PFE) and BioNTech (BNTX). The vaccine should provide a sharp increase in revenue. The company also has a diversified product portfolio.

Zones

For those following the Good Way, the Buy Now rating is ‘YES.’

For those following the Best Way the buy zone is $23 to $26.76.  MRVI is trading at $26.31 as of this writing in the premarket.

The stop zone is $21.38 to $22.33.  The first target zone is $29 to $32.  The second target zone is $35 to $38. The maximum quantity is 30% of full core position size.

So far this company has not caught the momo crowd’s attention.  If it catches the momo crowd’s attention, it has the potential to move up rapidly. On the other hand, if this stock does not get pumped by the pumpers, it is likely to be a slow grind up until earnings are released.

Caution: this is a recent IPO. As such, there is not a lot of historical data to analyze.  From a technical perspective, the stock has traded as high as $32.46 and a pullback provides an opportunity.

This post was just published on ZYX Buy Change Alert.

 

Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE
TRIAL TO PAID SERVICES.

See also  WEEKLY STOCK MARKET DIGEST: WHAT PRUDENT INVESTORS NEED TO KNOW NOW

Please click here to take advantage of a FREE 30 day trial.

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • BNTX, MRVI, PFE

Subscribe to 'Generate Wealth'

Free Forever

PrevPrevious
NextNext

More To Explore

HOPIUM BUYING – INDIA READY TO CUT TARIFFS TO 4%, TRUMP FLOATS CHINA TARIFFS AT 80%, UK NOT A MODEL

May 9, 2025

ADD TO AAPL AND GOOG HEDGES OR TAKE PARTIAL PROFITS — APPLE CONSIDERING AI SEARCH

May 8, 2025

30 Day Free Trial

Cancel within 30 days and you owe nothing

When you take a FREE 30 day trial, you get access to powerful techniques used by billionaires and hedge funds to grow richer. You can continue to use these powerful techniques to grow richer even if you cancel your subscription. You come out ahead by subscribing no matter how you look at it.

Subscribe Now

MOST ACCURATE

Follow the most accurate stock market, gold, and oil analysis in bull and bear markets — easily verifiable. When you subscribe, you get years of archives.

UNRIVALED PERFORMANCE

Thousands of investors, investment advisors, and money managers have witnessed the unrivaled performance of The Arora Report over both bull and bear markets. The secret is unique ZYX Change Method and ZYX Global Allocation Model.

100 MILLION PAGE VIEWS

Nigam Arora’s writings have gained over 100 million page views. Thousands of investors, investment advisors, and money managers, across the globe have benefited from accurate calls. 

Contact Us   Please review Terms of Use    Privacy Policy

Nigam Arora holds the patent with 28 claims on the ZYX Method. 'The Arora Report', 'ZYX Change Method' 'A Better Way to Invest', 'Money Flow News' and 'Theory ZYX' are registered trademarks. Copyright © The Arora Report, Ltd.

MOST ACCURATE

Follow the most accurate stock market, gold, and oil analysis in bull and bear markets — easily verifiable. When you subscribe, you get years of archives.

UNRIVALED PERFORMANCE

Thousands of investors, investment advisors, and money managers have witnessed the unrivaled performance of The Arora Report over both bull and bear markets. The secret is unique ZYX Change Method and ZYX Global Allocation Model.

100 MILLION PAGE VIEWS

Nigam Arora’s writings have gained over 100 million page views. Thousands of investors, investment advisors, and money managers, across the globe have benefited from accurate calls. 

Contact Us    Please review Terms of Use    Privacy Policy

Nigam Arora holds the patent with 28 claims on the ZYX Method. 'The Arora Report', 'ZYX Change Method' 'A Better Way to Invest', 'Money Flow News' and 'Theory ZYX' are registered trademarks. Copyright © The Arora Report, Ltd.

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy

Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset